{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:16:48Z","timestamp":1793067408659,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10875-021-01103-6","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T05:03:14Z","timestamp":1632891794000},"page":"36-45","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Reduced-Intensity\/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD"],"prefix":"10.1007","volume":"42","author":[{"given":"Danielle E.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rofida","family":"Nofal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lehmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Wustrau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Heimall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Bunin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Brettig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Speckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Salamonowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Wahlstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9645-0617","authenticated-orcid":false,"given":"Rebecca A.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"issue":"7115","key":"1103_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature05257","volume":"444","author":"S Rigaud","year":"2006","unstructured":"Rigaud S, Fondaneche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006;444(7115):110\u20134.","journal-title":"Nature"},{"issue":"3","key":"1103_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/sj.emboj.7600544","volume":"24","author":"FL Scott","year":"2005","unstructured":"Scott FL, Denault JB, Riedl SJ, Shin H, Renatus M, Salvesen GS. XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J. 2005;24(3):645\u201355.","journal-title":"EMBO J"},{"issue":"5","key":"1103_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0092-8674(01)00272-0","volume":"104","author":"J Chai","year":"2001","unstructured":"Chai J, Shiozaki E, Srinivasula SM, et al. Structural basis of caspase-7 inhibition by XIAP. Cell. 2001;104(5):769\u201380.","journal-title":"Cell"},{"issue":"2","key":"1103_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1097-2765(03)00054-6","volume":"11","author":"EN Shiozaki","year":"2003","unstructured":"Shiozaki EN, Chai J, Rigotti DJ, et al. Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell. 2003;11(2):519\u201327.","journal-title":"Mol Cell"},{"issue":"5","key":"1103_CR5","first-page":"781","volume":"104","author":"Y Huang","year":"2001","unstructured":"Huang Y, Park YC, Rich RL, Segal D, Myszka DG, Wu H. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell. 2001;104(5):781\u201390.","journal-title":"Cell"},{"issue":"34","key":"1103_CR6","doi-asserted-by":"publisher","first-page":"14524","DOI":"10.1073\/pnas.0907131106","volume":"106","author":"A Krieg","year":"2009","unstructured":"Krieg A, Correa RG, Garrison JB, et al. XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci U S A. 2009;106(34):14524\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1103_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.molcel.2018.01.016","volume":"69","author":"T Goncharov","year":"2018","unstructured":"Goncharov T, Hedayati S, Mulvihill MM, et al. Disruption of XIAP-RIP2 association blocks NOD2-mediated inflammatory signaling. Mol Cell. 2018;69(4):551-565 e557.","journal-title":"Mol Cell"},{"issue":"6","key":"1103_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.molcel.2012.04.014","volume":"46","author":"RB Damgaard","year":"2012","unstructured":"Damgaard RB, Nachbur U, Yabal M, et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell. 2012;46(6):746\u201358.","journal-title":"Mol Cell"},{"issue":"8","key":"1103_CR9","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/emmm.201303090","volume":"5","author":"RB Damgaard","year":"2013","unstructured":"Damgaard RB, Fiil BK, Speckmann C, et al. Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling. EMBO Mol Med. 2013;5(8):1278\u201395.","journal-title":"EMBO Mol Med"},{"issue":"3","key":"1103_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/cei.12306","volume":"176","author":"S Ammann","year":"2014","unstructured":"Ammann S, Elling R, Gyrd-Hansen M, et al. A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency. Clin Exp Immunol. 2014;176(3):394\u2013400.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"1103_CR11","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/emboj.2012.18","volume":"31","author":"M Moulin","year":"2012","unstructured":"Moulin M, Anderton H, Voss AK, et al. IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J. 2012;31(7):1679\u201391.","journal-title":"EMBO J"},{"issue":"6","key":"1103_CR12","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.celrep.2014.05.008","volume":"7","author":"M Yabal","year":"2014","unstructured":"Yabal M, Muller N, Adler H, et al. XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Rep. 2014;7(6):1796\u2013808.","journal-title":"Cell Rep"},{"issue":"2","key":"1103_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.immuni.2012.01.012","volume":"36","author":"JE Vince","year":"2012","unstructured":"Vince JE, Wong WW, Gentle I, et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity. 2012;36(2):215\u201327.","journal-title":"Immunity"},{"issue":"16","key":"1103_CR14","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1182\/blood-2013-06-510743","volume":"123","author":"WW Wong","year":"2014","unstructured":"Wong WW, Vince JE, Lalaoui N, et al. cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner. Blood. 2014;123(16):2562\u201372.","journal-title":"Blood"},{"issue":"10","key":"1103_CR15","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41419-019-1938-x","volume":"10","author":"J Knop","year":"2019","unstructured":"Knop J, Spilgies LM, Rufli S, et al. TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP. Cell Death Dis. 2019;10(10):700.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1103_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cyto.2013.09.007","volume":"65","author":"T Wada","year":"2014","unstructured":"Wada T, Kanegane H, Ohta K, et al. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine. 2014;65(1):74\u20138.","journal-title":"Cytokine"},{"issue":"7","key":"1103_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","volume":"116","author":"RA Marsh","year":"2010","unstructured":"Marsh RA, Madden L, Kitchen BJ, et al. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 2010;116(7):1079\u201382.","journal-title":"Blood"},{"issue":"3","key":"1103_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10875-011-9638-z","volume":"32","author":"X Yang","year":"2012","unstructured":"Yang X, Kanegane H, Nishida N, et al. Clinical and genetic characteristics of XIAP deficiency in Japan. J Clin Immunol. 2012;32(3):411\u201320.","journal-title":"J Clin Immunol"},{"issue":"5","key":"1103_CR19","doi-asserted-by":"publisher","first-page":"e27593","DOI":"10.1002\/pbc.27593","volume":"66","author":"M Shabani","year":"2019","unstructured":"Shabani M, Razaghian A, Alimadadi H, Shiari R, Shahrooei M, Parvaneh N. Different phenotypes of the same XIAP mutation in a family: a case of XIAP deficiency with juvenile idiopathic arthritis. Pediatr Blood Cancer. 2019;66(5):e27593.","journal-title":"Pediatr Blood Cancer."},{"issue":"1","key":"1103_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clim.2013.07.004","volume":"149","author":"C Speckmann","year":"2013","unstructured":"Speckmann C, Lehmberg K, Albert MH, et al. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol. 2013;149(1):133\u201341.","journal-title":"Clin Immunol"},{"issue":"8","key":"1103_CR21","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/RHU.0000000000000327","volume":"21","author":"ML Basiaga","year":"2015","unstructured":"Basiaga ML, Weiss PF, Behrens EM. BIRC4 Mutation: An Important Rare Cause of Uveitis. J Clin Rheumatol. 2015;21(8):444\u20137.","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"1103_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/gutjnl-2013-306520","volume":"64","author":"Y Zeissig","year":"2015","unstructured":"Zeissig Y, Petersen BS, Milutinovic S, et al. XIAP variants in male Crohn\u2019s disease. Gut. 2015;64(1):66\u201376.","journal-title":"Gut"},{"issue":"5","key":"1103_CR23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jaci.2014.04.031","volume":"134","author":"C Aguilar","year":"2014","unstructured":"Aguilar C, Lenoir C, Lambert N, et al. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J Allergy Clin Immunol. 2014;134(5):1131-1141 e1139.","journal-title":"J Allergy Clin Immunol."},{"issue":"6","key":"1103_CR24","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1182\/blood-2012-06-432500","volume":"121","author":"RA Marsh","year":"2013","unstructured":"Marsh RA, Rao K, Satwani P, et al. Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes. Blood. 2013;121(6):877\u201383.","journal-title":"Blood"},{"issue":"Suppl 2","key":"1103_CR25","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1038\/bmt.2008.283","volume":"42","author":"N Cooper","year":"2008","unstructured":"Cooper N, Rao K, Goulden N, Webb D, Amrolia P, Veys P. The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis. Bone Marrow Transplant. 2008;42(Suppl 2):S47-50.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"1103_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1365-2141.2011.08785.x","volume":"154","author":"RA Marsh","year":"2011","unstructured":"Marsh RA, Jordan MB, Filipovich AH. Reduced-intensity conditioning haematopoietic cell transplantation for haemophagocytic lymphohistiocytosis: an important step forward. Br J Haematol. 2011;154(5):556\u201363.","journal-title":"Br J Haematol"},{"issue":"6","key":"1103_CR27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41409-018-0125-5","volume":"53","author":"S Richards","year":"2018","unstructured":"Richards S, Choo S, Mechinaud F, Cole T. Single centre results of targeted busulphan, fludarabine and serotherapy conditioning in haematopoietic stem cell transplantation for haemophagocytic lymphohistiocytosis. Bone Marrow Transplant. 2018;53(6):784\u20136.","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"1103_CR28","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1182\/bloodadvances.2020001748","volume":"4","author":"M Felber","year":"2020","unstructured":"Felber M, Steward CG, Kentouche K, et al. Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis. Blood Adv. 2020;4(9):1998\u20132010.","journal-title":"Blood Adv"},{"issue":"1","key":"1103_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10875-016-0348-4","volume":"37","author":"S Ono","year":"2017","unstructured":"Ono S, Okano T, Hoshino A, et al. Hematopoietic stem cell transplantation for XIAP deficiency in Japan. J Clin Immunol. 2017;37(1):85\u201391.","journal-title":"J Clin Immunol"},{"issue":"19","key":"1103_CR30","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1182\/bloodadvances.2017004242","volume":"1","author":"T Toubai","year":"2017","unstructured":"Toubai T, Rossi C, Oravecz-Wilson K, et al. IAPs protect host target tissues from graft-versus-host disease in mice. Blood Adv. 2017;1(19):1517\u201332.","journal-title":"Blood Adv"},{"issue":"3","key":"1103_CR31","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/eji.201847818","volume":"49","author":"N Muller","year":"2019","unstructured":"Muller N, Fischer JC, Yabal M, Haas T, Poeck H, Jost PJ. XIAP deficiency in hematopoietic recipient cells drives donor T-cell activation and GvHD in mice. Eur J Immunol. 2019;49(3):504\u20137.","journal-title":"Eur J Immunol"},{"issue":"12","key":"1103_CR32","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15(12):1628\u201333.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"1103_CR33","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, et al. Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15(6):825\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"1103_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","volume":"57","author":"KM Sullivan","year":"1981","unstructured":"Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57(2):267\u201376.","journal-title":"Blood"},{"issue":"6","key":"1103_CR35","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.jaci.2018.08.010","volume":"142","author":"RA Marsh","year":"2018","unstructured":"Marsh RA, Hebert KM, Keesler D, et al. Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies. J Allergy Clin Immunol. 2018;142(6):2004\u20137.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01103-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-021-01103-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01103-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T11:07:44Z","timestamp":1744110464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-021-01103-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1103"],"URL":"https:\/\/doi.org\/10.1007\/s10875-021-01103-6","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Cincinnati Children\u2019s Hospital institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"JW is employed by AbbVie. AK and MBJ have done ad hoc consultancy for Swedish Orphan Biovitrum. CB has done ad hoc consultancy for Novimmune and Swedish Orphan Biovitrum. The remaining authors have no relevant conflicts of interest to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}